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Routine measurement of the outcome of clinical care is increasingly considered important in health care. It is a key aspect 
of value-based health care, patient-centered care, 
and other quality-of-care initiatives.1 For example, 
the Dutch government strives to have objective 
outcome data on 50 percent of all health care in 
2022,2 and in Sweden, outcome measurements 
have been part of a national registry for years.3
The goals of routine outcome measurement 
are multiple, including improving communication 
and treatment guidance at the patient level, in 
addition to benchmarking of outcome at the 
level of individual clinicians or treatment centers. 
This benchmark information may help to estab-
lish priorities in resource allocation, and provide 
clinicians and managers with valuable feedback 
on performance. Furthermore, routine outcome 
measurement systems generate large data sets 
that can be used in scientific research. These “big 
data” can help provide knowledge on, for exam-
ple, comparative effectiveness, predictive factors 
of outcome, and psychometric properties of mea-
surement instruments.
Although routine outcome measurement 
has been advocated for years, implementation 
in clinical practice is limited because of several 
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challenges. These include lack of (1) consensus 
on which outcome measurements should be col-
lected; (2) appropriate information technology 
infrastructure for data collection; (3) time and 
financial resources for data collection; (4) com-
pliance of both patients and health care providers 
in data collection; (5) analysis and visualization 
tools; and (6) knowledge to improve clinical care 
by using the data.
In 2009, Xpert Clinic, Handtherapie Neder-
land, and Erasmus MC, University Medical Center 
Rotterdam started an initiative to collect routine 
outcome data in all patients with hand and wrist 
disorders undergoing surgical or nonsurgical 
treatment in their centers. This article provides an 
overview of this routine outcome measurement 
cohort by describing its design, development, and 
implementation. Furthermore, we describe how 
the accumulated data are used to improve the 
quality of health care and facilitate ongoing sci-
entific research. By sharing our lessons learned, 
we hope to help others overcome the hurdles to 
implement routine outcome measurement.
PATIENTS AND METHODS
Treatment Locations and Patient Population
Routine outcome measurement was imple-
mented in 2011 at all practice sites (currently n = 
22) of Xpert Clinic and Handtherapie Nederland 
across The Netherlands. Presently, 23 European 
Board–certified (Federation of European Societ-
ies for Surgery of the Hand) hand surgeons, mul-
tiple hand surgery fellows, and more than 150 
hand therapists are employed within these orga-
nizations. The organizations provide nonsurgical 
and surgical treatment for acute and nonacute 
hand and wrist disorders, excluding emergency 
care. Patients are referred by either their general 
practitioner or another medical specialist. Surgi-
cal treatment is performed only in patients with 
an American Society of Anesthesiologists score of 
1 to 2. Table 1 shows an overview of the most com-
mon disorders and treatments.
Before any measurement or treatment, all 
patients are digitally asked for permission to use 
their data anonymously for scientific research. 
If a patient does not provide informed consent, 
the data will only be used for direct health care 
purposes but not for scientific analysis. Patients 
can always withdraw their consent. Access to all 
questionnaires, including the one on informed 
consent, is restricted through the use of a unique 
secret identifier provided to the individual patient 
by e-mail. Approval from the local medical ethical 
review board is obtained for each scientific study 
that uses the data.
Measurements
In 2010, a working group consisting of hand 
surgeons, hand therapists, and researchers from 
Xpert Clinic, Handtherapie Nederland, and Eras-
mus MC developed a measurement set based on 
existing guidelines.4 Instruments were considered 
if they were of direct use for clinical care, quality 
assessment, or treatment outcome evaluation and 
had proper psychometric properties.4 Measure-
ments only relevant for scientific research or anal-
yses of underlying abnormality (e.g., radiographic 
imaging or electromyography) were excluded 
from routine registration. All measurements were 
kept to a minimum to reduce the burden and 
optimize compliance.
The clinician-reported outcome measure-
ments include grip and pinch strength and range 
of motion, whereas patient-reported outcome 
measurements include pain, hand function, aes-
thetics, return to work/daily activities, and satis-
faction with the outcome. Furthermore, the Dutch 
Patient Reported Experience Measure is used.5
Next, we created “measurement tracks,” consist-
ing of a specific set of measurements administered 
at predetermined time points for each treatment or 
condition. We aimed to create as few measurement 
tracks as possible, based on similarity in the rele-
vance of outcome domains and time points needed 
to capture the patients’ health status. Eventually, 
five main measurement tracks were developed: (1) 
thumb disorders, (2) wrist disorders, (3) finger 
disorders, (4) Dupuytren’s disease, and (5) com-
pression neuropathy. The thumb, wrist, and finger 
tracks were further divided into a “regular” track, 
including shorter follow-up and fewer measure-
ments (e.g., for trigger finger); and an “extended” 
track, including longer follow-up and more mea-
surements (e.g., for thumb base surgery). For all 
measurement tracks, selected time points were 
baseline and combinations of 6 weeks and 3, 6, and 
12 months after treatment (Table 2). Table 2 shows 
the content of each measurement track, which is 
reviewed and updated every 2 years. If a patient 
receives multiple concurrent treatments, only one 
track is assigned at treatment onset by the hand 
therapist in collaboration with the hand surgeon. 
To select this single track, we developed a prior-
ity rule based on the treatment that we expected, 
on average, to have the most impact (Table 1). 
Although only a single track is assigned in these 
cases, all concurrent treatments are registered. The 
same priority rule is applied when a new treatment 
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starts during an already active measurement track 
(e.g., 3 months postoperatively) to determine 
whether a new track needs to be assigned.
Measurement Logistics and Data Collection
For efficient implementation of routine out-
come measurement, measurement time points 
were aligned with the sequence of care events of 
typical patients (Fig. 1). For example, when a first 
consultation is registered in the electronic patient 
record, this initiates the distribution of baseline 
questionnaires assessing risk factors (e.g., smok-
ing, comorbidity, and medical history) and patient 
expectations of the consultation and treatment. 
Then, during the first consultation, a hand sur-
geon registers the diagnosis and decides together 
with the patient to start either nonsurgical or surgi-
cal treatment. Based on this information, a hand 
therapist assigns a specific measurement track. At 
the same visit, the hand therapist records patient 
demographics (e.g., hand dominance) and clini-
cian-reported outcome measurements and informs 
the patient on the treatment and future measure-
ments. Subsequently, patient-reported outcome 
measurements are e-mailed to the patient. The 
start of nonsurgical treatment or the date of sur-
gery determines the timing of future question-
naires or assessments. To guarantee the validity 
and reliability of our data, all therapists received 
specific training on performing the measurements.
All data are collected digitally in an online sys-
tem named Pulse, which was developed using Gem-
sTracker electronic data capture tools.6 GemsTracker 
is a secure, open-source, Web-based application for 
distribution of questionnaires and forms for clinical 
research and quality registration. GemsTracker uses 
the open-source software LimeSurvey7 for building 
and storing questionnaires. To ensure data safety, 
measurements are administered using methods 
similar to those in electronic patient records, includ-
ing annual audits and tests, two-way authentication 
login, and logging and monitoring of all activity.
Because Pulse is linked to our electronic 
patient records, it automatically sends invitational 
e-mails to patients for completing questionnaires 
as soon as a diagnosis and treatment onset are 
assigned to a patient in the electronic patient 
record. Also, health care providers can access 
Pulse and see which measurements they need to 
complete for a specific patient.
Pulse directly calculates scores of patient-
reported outcome measurements and displays an 
overview of answered, open, and missed measures. 
When the same measure is administered multiple 
times within a track, score development over time 
is displayed. In the case patient-reported outcome 
Table 2. Overview of the Predefined Tracks, Their Measurements, and Time Points* 
Track Baseline 6 Wk 3 Mo 6 Mo 12 No
All tracks •  VAS: pain, 
function, 
satisfaction
•  PSFS
•  VAS: pain, 
function, 
satisfaction
•  PSFS
•  Return to work
•  Satisfaction 
treatment result
•  VAS: pain, 
function, 
satisfaction
•  PSFS
•  Return to work
•  Satisfaction 
treatment result
•  PREM
•  VAS: pain, 
function, 
satisfaction†
•  PSFS†
•  Return to work†
•  Satisfaction 
treatment result†
•  VAS: pain, 
function, 
satisfaction
•  PSFS
•  Return to work
•  Satisfaction 
treatment result
Thumb •  MHQ
•  Thumb ROM†
•  Grip and pinch 
strength†
— •  MHQ
•  Thumb ROM†
•  Grip and pinch 
strength†
— •  MHQ
•  Thumb ROM†
•  Grip and pinch 
strength†
Finger •  MHQ
•  Finger ROM†
•  Grip strength†
•  MHQ
•  Finger ROM†
•  Grip strength†
— •  MHQ
•  Finger ROM†
•  Grip strength†
Wrist •  PRWHE
•  Wrist ROM†
•  Grip strength†
•  PRWHE
•  Wrist ROM†
•  Grip strength†
— •  PRWHE
•  Wrist ROM†
•  Grip strength†
Compression 
neuropathy
•  BCTQ •  BCTQ •  BCTQ —
Dupuytren •  MHQ
•  Finger and/or 
thumb ROM
•  MHQ
•  Finger and/or 
thumb ROM
— •  MHQ
•  Finger and/or 
thumb ROM
MHQ, Michigan Hand Outcome Questionnaire; VAS, visual analogue scale; VAS Function, visual analogue scale for hand function; PREM, 
Patient-Reported Experience Measure; PRWHE, Patient-Rated Wrist-Hand Evaluation; BCTQ, Boston Carpal Tunnel Questionnaire, ROM; 
range of motion; Satisfaction, satisfaction with the outcome of treatment; PSFS, Patient-Specific Functional Scale.
*This table shows the measurements performed in all tracks and the additional measurements performed in each specific track. For each type 
of treatment, it was decided whether patients would be assigned a regular track with a short follow-up of maximally 3 mo or an extended track 
with a 12-mo follow-up and more extensive measurements.
†Measurements performed only in the extended tracks for a specific time point.
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measurements data are missing, the surgeon or 
therapist can request the patient to complete the 
missing questionnaires, but treatment can also 
continue without this information.
RESULTS
Collected Data
Figure 2 shows the number of tracks assigned 
to patients over the years. The total number of 
yearly assigned tracks increased up to over 16,300 in 
2018, adding up to a total of 85,000 tracks in 52,000 
patients. The increase in the track numbers reflects 
the growth in treatment volume and the opening of 
new centers. The regular tracks, which include non-
surgical treatments (e.g., orthotics, exercise therapy, 
injections) and minor surgical interventions (e.g., 
trigger finger release), were more often assigned 
than extended tracks, which include more invasive 
surgery. Table 3 shows that the Michigan Hand Out-
comes Questionnaire, Patient-Rated Wrist/Hand 
Evaluation, and our Patient-Reported Experience 
Measure are the most time-consuming measures, 
with a median of 3 to 4 minutes to complete. These 
completion times are lower than initially reported; 
for example, the Michigan Hand Outcomes Ques-
tionnaire is reported to take approximately 15 min-
utes to complete according to its developers.8
Fig. 1. Flowchart of measurement timing relative to common care paths of patients. 
Because the measurement system is coupled to electronic patient records with care 
information, measurements, and questionnaires e-mailed to patients, it can be fully 
automated as soon as nonsurgical or surgical treatment is entered into the system. 
PROM, patient-reported outcome measure; CROM, clinician-reported outcome mea-
sure; PREM, Patient-Reported Experience Measure.
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Patient compliance for completing question-
naires was highest at baseline. For example, for 
pain, hand function, and satisfaction question-
naires, compliance was 73 percent at baseline 
and decreased to 62 percent at 12 months (Fig. 3, 
above). Compliance in extended tracks was 8 per-
cent higher at baseline and 14 percent higher at 
3 months compared to regular tracks. Compli-
ance also decreased at follow-up for clinician-
reported outcome measurements (Fig. 3, below); at 
baseline, 90 percent of measurement forms were 
completed, whereas at 3 and 12 months, these 
numbers decreased to 50 percent and 38 percent, 
respectively.
Using Outcome Data in Clinical Practice
From the start in 2011, all surgeons, thera-
pists, and staff had direct access to all scores of 
individual patients and their development over 
time. Thus, for example, hand therapists use the 
measurements to evaluate treatment progress and 
set new treatment goals. Also, we introduced an 
integrated secure patient portal (Fig. 4) to allow 
patients to access their treatment information. 
Within this portal, patients can complete their 
questionnaires and see their progress over time. 
Based on the assigned treatment, patient-specific 
treatment information is provided (e.g., disease-
specific instructional videos on postoperative 
exercises). In 2018, approximately 3100 patients 
logged into their patient portal each month.
From 2017 onward, we show individual 
patient outcomes relative to the average outcome 
from previous patients. For example, patients can 
see their pain score over time relative to mean 
scores of previous patients undergoing the same 
treatment (Fig. 5). Moreover, we introduced a 
physician dashboard, where physician-specific 
outcomes for more than 100 treatments are com-
pared to the average of all other physicians.
Fig. 2. The number of yearly activated measurement tracks. Dashed lines indicate the regu-
lar tracks; solid lines indicate the extended tracks. Note that more than one measurement track 
can be assigned to a patient, for example, when a new treatment track (e.g., surgery) is initiated 
after an initial treatment track failed to obtain sufficient relief of symptoms (e.g., an injection or 
hand therapy). The decrease in track assignment in 2015 and 2016 was attributable to organiza-
tional problems leading to a significant number of patients where a measurement track was not 
assigned at the start of treatment. However, as can be seen, this improved by 2017.
Table 3. Total Number of Patient Questionnaires 
across All Tracks and the Median Time to Complete 
the Questionnaires from 2011 to 2018
Questionnaire
No. of  
Completed  
Questionnaires
Median  
Time to Complete 
(min:sec)
MHQ 49,925 4:15 
PRWHE 28,784 3:43 
BCTQ 17,680 1:54 
Return to work 40,998 0:39 
Satisfaction with result 81,534 0:14 
VAS pain and function 135,074 0:33 
PREM 25,407 4:17 
MHQ, Michigan Hand Outcome Questionnaire; PRWHE, Patient-
Rated Wrist-Hand Evaluation; BCTQ, Boston Carpal Tunnel Ques-
tionnaire; VAS, visual analogue scale; PREM, Patient-Reported 
Experience Measure.
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Scientific Research with the Collected Data
Although our data collection system was 
designed primarily to improve and monitor the 
quality of health care of our patients, the system 
also constitutes a cohort of high-quality data suit-
able for scientific research: the Hand-Wrist Study 
Group Cohort.
Comparative Effectiveness and Prediction 
Modeling
Our first published studies9–13 focused 
on comparative effectiveness. In these stud-
ies, variation in daily clinical practice is used 
to compare different treatments (e.g., when 
different surgeons prefer different treatments 
in the same patient population). To correct for 
baseline differences between treatment groups, 
we use propensity score matching and mixed 
models. For example, we showed that collage-
nase clostridium histolyticum in Dupuytren’s 
disease was not significantly different from 
limited fasciectomy in reducing metacarpo-
phalangeal joint contractures in short-term 
outcome, whereas proximal interphalangeal 
joint contractures showed slightly better reduc-
tion following limited fasciectomy.3 Further-
more, we demonstrated that exercise therapy 
in addition to an orthosis reduces pain more 
Fig. 3. (Above) Compliance of hand therapists filling in the clinician-reported outcome mea-
surements, such as goniometry and grip strength. There are differences in compliance between 
measurement tracks, but the most important factor is the duration of the follow-up. (Below) Com-
pliance of patients completing the patient-reported outcome measurements, illustrated using 
the compliance on the visual analogue scale for pain, hand function, and satisfaction.
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compared to an orthosis only in patients with 
thumb base osteoarthritis13 and that, follow-
ing a thumb carpometacarpal resection arthro-
plasty, shorter immobilization is noninferior 
compared to more prolonged immobiliza-
tion.10 In addition to comparative effectiveness, 
we use our data to develop and validate prog-
nostic and clinical prediction models that allow 
outcome prediction of individual patients, for 
example, on the outcome of nonsurgical treat-
ment for thumb base osteoarthritis,13–16 surgical 
treatment of primary or recurrent carpal tun-
nel syndrome,17–19 and surgery in Dupuytren’s 
contracture.20,21
Health Care Context and Treatment Outcomes
We also study how outcomes are influenced 
not only by treatment but also by the process 
of care delivery and patient experiences. More 
specifically, we consistently found positive asso-
ciations between patient experiences on care 
delivery and improvement in patient-reported 
outcome measures following surgical treat-
ments.5,22,23 The strongest associations were 
found for positive experiences with the com-
munication of the surgeon and providing treat-
ment information, which is in line with other 
studies.5,22,23
Clinimetric Studies
The collected data also allow evaluating the 
psychometric measurement properties. For exam-
ple, in patients with Dupuytren’s contracture, we 
reported that the Patient-Specific Functional Scale 
is more responsive than the more generic and 
standardized Michigan Hand Outcomes Ques-
tionnaire, despite being much shorter to fill in.24 
In addition, we developed decision tree–based 
versions of the Patient-Rated Wrist/Hand Evalu-
ation25 and the Boston Carpal Tunnel Question-
naire26 to reduce the number of items needed to 
calculate the total score from 15 and 18 to six for 
both patient-reported outcome measures, without 
loss of information (see http://handquestion-
naires.org).
DISCUSSION
We introduce the design, development, and 
implementation of a routine outcome measure-
ment system in hand and wrist care, describing 
how our data are collected and used for improving 
clinical care and performing scientific research. 
The system was made feasible by using a highly 
automated data collection infrastructure, tightly 
linked to the patient journey and the workflow 
of health care professionals. With this article, we 
Fig. 4. Screenshot of the personalized patient portal, where patients can learn about the treatment, health care process, expected 
outcomes, and exercises and can also complete the required questionnaires. As soon as a measurement track is assigned to a 
patient, disease-specific information is provided.
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intend to share our experiences in designing such 
a system and our lessons learned, and to describe 
the remaining challenges.
The design and implementation of our routine 
outcome measurement system were facilitated by 
the specific expertise of the collaborating parties. 
The Erasmus MC, as a large academic center, con-
tributes scientific knowledge, and Xpert Clinic, as a 
highly specialized hand and wrist clinic, can quickly 
innovate and integrate the measurements in their 
workflow. By developing dedicated software,6 we 
could customize the data collection to our specific 
needs and implement changes efficiently.
Ensuring high compliance of both patients 
and clinicians remains a challenge, as in all out-
come measurement systems.27 We took several 
measures to optimize compliance. A first step was 
to minimize the measurement burden and allow 
direct measurement feedback to both patients 
and clinicians. A second step was to improve data 
integration during consultations and therapy. For 
instance, instead of asking for limitations in daily 
life during a patient’s first visit, clinicians can now 
see this information beforehand and can discuss 
these issues directly. As a third step, we visualize 
individual outcomes relative to other patients, 
Fig. 5. Screenshot of a physician dashboard, showing the individual patient’s outcome (magenta line) compared to the 
“average patient’s” outcomes (blue line, p50; and blue area, p25 to p75) after a carpal tunnel release. The data shown can be 
modified by the user, who can select a treatment, a treatment location, and a surgeon. These outcomes will then be plotted 
compared to the outcomes of all other surgeons at all treatment locations for that treatment. (Screenshot published with 
permission from Xpert Clinic.)
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which provides a reference for both patient and 
clinician to discuss treatment outcomes. At pres-
ent, we present outcomes as group means plus 
confidence intervals at the level of specific treat-
ments (e.g., a trapeziectomy) but this can be fur-
ther personalized to individuals (e.g., a 70-year-old 
woman with a baseline Michigan Hand Outcomes 
Questionnaire score of 50). Thus, in the future, 
we plan to extend this and present individualized 
outcome predictions based on existing data.
Although clinicians value outcome informa-
tion, more research is needed on how to effi-
ciently use outcome data to improve quality of 
care and maintain practical feasibility. Presently, 
it remains challenging for clinicians to actually 
use the data in daily practice, for a variety of rea-
sons, such as lack of time or inexperience in how 
to use the data in daily clinical practice. Another 
concern is that a multitude of factors can influ-
ence expected outcomes for an individual patient 
that need to be taken into account when discuss-
ing the expected outcome with a patient. There-
fore, we are presently developing models that can 
predict outcome for individual patients. Our cur-
rent efforts are focused on the implementation of 
these models in daily clinical practice so that they 
can be used in real time during consultation. In 
addition, in the future, we plan to link outcome 
data with the cost of treatment as recorded in the 
electronic health care record, providing insight 
into the quality of care from a value-based health 
care perspective.
We found that efficient data acquisition soft-
ware allows outcome recording with a relatively 
small time investment per patient. Furthermore, 
at present, the main costs include software devel-
opment and maintenance (approximately 2 to 3 
full-time equivalents throughout the last years for 
all participating treatment centers) and the efforts 
of staff, management, and researchers to design 
the system. By making the GemsTracker software 
open-source and describing our procedures in 
detail, we intend to lower the costs for new cen-
ters to develop a similar system. However, despite 
our successful implementation, reimbursement 
by health care insurance companies for outcome 
measurement remains unusual, despite the wish 
of insurance companies and the government to 
collect outcome data. Thus, further collaboration 
between health care providers, scientists, insur-
ance companies, and governments is needed, 
because these investments are currently being 
made by health care organizations themselves.
When comparing the Hand-Wrist Study 
Group cohort with other large cohorts and related 
initiatives, there are significant similarities and 
differences. For example, registries such as the 
Swedish hand registry28 have larger patient num-
bers but less detailed information. Other com-
monly used cohorts consist of administrative or 
claim data on the hospital, regional, or national 
level.29–32 To our knowledge, the present cohort is 
unique within the field of hand and wrist disorders 
because it contains a large number of patients with 
relatively detailed data, covering both outcomes, 
treatment information, and patient characteris-
tics. A limitation, however, is that this cohort is 
not representative of all hand and wrist patients in 
The Netherlands, for example, because complex 
trauma patients and patients with more severe 
comorbidities may be treated more often else-
where. Also, if patients seek treatment elsewhere, 
no follow-up is available.
For all clinical (e.g., quality evaluation and 
benchmarking) and scientific analysis, missing 
data are always an important issue. In several of 
our research articles, we have performed exten-
sive missing data analysis and have consistently 
found that our data can be qualified as missing 
completely at random.33–36 In the literature, many 
statistical analyses and simulation articles have 
indicated that either multiple imputation tech-
niques or analyses that account for missing data 
are superior to complete case analyses.33–37 How-
ever, we noticed that such techniques are coun-
terintuitive to many readers. Consequently, we 
have frequently been asked by journal reviewers 
to report complete cases, despite literature advis-
ing otherwise.
Because measuring outcomes is central in 
value-based health care,1 it would be of great 
value if more health care providers in hand and 
wrist care would routinely measure outcomes. 
Although there have been several consensus ini-
tiatives on outcome sets,28,38–41 none has led to 
widespread implementation. We hope that our 
example of routine outcome measurement imple-
mentation and the development of the hand and 
wrist standard set by the International Consortium 
for Health Outcome Measurement42 will lead to a 
common ground for more widespread compari-
sons of outcomes.
Ruud W. Selles, Ph.D.
Department of Rehabilitation Medicine
Department of Plastic and Reconstructive Surgery and 
Hand Surgery
Erasmus MC, University Medical Center Rotterdam
P.O. Box 2040
3000 CA Rotterdam, The Netherlands
r.selles@erasmusmc.nl
Twitter: @ruudselles
Copyright ©  American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited. 
Volume 146, Number 2 • The Hand-Wrist Study Group Cohort
353
ACKNOWLEDGMENTS
The authors thank all patients who completed ques-
tionnaires as part of their clinical care and agreed for 
their data to be used in scientific studies. In addition, 
they would like to acknowledge the members of the Hand-
Wrist Study Group, health care providers and personnel 
of Xpert Clinic, Handtherapie Nederland, and Equipe 
Zorgbedrijven, for facilitating the routine outcome mea-
surements that are the basis for this article.
REFERENCES
 1. Porter ME. What is value in health care? N Engl J Med. 
2010;363:2477–2481. 
 2. Dutch National Health Care Institute. Meer patiëntregie 
door meer uitkomstinformatie in 2022. Available at: https://
www.zorginstituutnederland.nl/werkagenda/publicaties/
rapport/2018/06/28/rapport-meer-patientregie-door-
meer-uitkomstinformatie-in-2022. Accessed June 8, 2020.
 3. Nilsson E, Orwelius L, Kristenson M. Patient-reported out-
comes in the Swedish National Quality Registers. J Intern 
Med. 2016;279:141–153. 
 4. American Society of Hand Therapists. Clinical Assessment 
Recommendations. 3rd ed. Mount Laurel, NJ: American 
Society of Hand Therapists; 2015.
 5. Poelstra R, Selles RW, Slijper HP, et al.; Hand-Wrist Study 
Group. Better patients’ treatment experiences are associ-
ated with better postoperative results in Dupuytren’s disease. 
J Hand Surg Eur Vol. 2018;43:848–854. 
 6. GemsTracker; Erasmus MC; Equipe Zorgbedrijven. 
GemsTrakcer, latest release at 2017, version 1.8.2, open 
source (new BSD licence). Available at: https://gemstracker.
org. Accessed June 8, 2020.
 7. LimeSurvey GmbH. LimeSurvey. Available at: https://www.
limesurvey.org/. Accessed June 8, 2020.
 8. Michigan Hand outcomes Questionnaire (MHQ). Available 
at: http://mhq.lab.medicine.umich.edu/home. Accessed 
June 8, 2020.
 9. Zhou C, Hovius SE, Slijper HP, et al. Collagenase clostrid-
ium histolyticum versus limited fasciectomy for Dupuytren’s 
contracture: Outcomes from a multicenter propensity score 
matched study. Plast Reconstr Surg. 2015;136:87–97. 
 10. Tsehaie J, Wouters RM, Feitz R, Slijper HP, Hovius SER, Selles 
RW; Hand-Wrist Study Group. Shorter vs longer immobiliza-
tion after surgery for thumb carpometacarpal osteoarthritis: 
A propensity score-matched study. Arch Phys Med Rehabil. 
2019;100:2022–2031.e1. 
 11. Zhou C, Selles RW, Slijper HP, et al. Comparative effective-
ness of percutaneous needle aponeurotomy and limited 
fasciectomy for Dupuytren’s contracture: A multicenter 
observational study. Plast Reconstr Surg. 2016;138:837–846. 
 12. Zhou C, Hovius SER, Pieters AJ, Slijper HP, Feitz R, Selles 
RW. Comparative effectiveness of needle aponeurotomy and 
collagenase injection for Dupuytren’s contracture: A multi-
center study. Plast Reconstr Surg Glob Open 2017;5:e1425. 
 13. Wouters RM, Tsehaie J, Slijper HP, Hovius SER, Feitz R, Selles 
RW; Hand-Wrist Study Group. Exercise therapy in addition 
to an orthosis reduces pain more than an orthosis alone in 
patients with thumb base osteoarthritis: A propensity score 
matching study. Arch Phys Med Rehabil. 2019;100:1050–1060. 
 14. Tsehaie J, Porsius JT, Rizopoulos D, et al. Response to conser-
vative treatment for thumb carpometacarpal osteoarthritis is 
associated with conversion to surgery: A prospective cohort 
study. Phys Ther. 2019;99:570–576. 
 15. Tsehaie J, Spekreijse KR, Wouters RM, et al. Outcome of a 
hand orthosis and hand therapy for carpometacarpal osteo-
arthritis in daily practice: A prospective cohort study. J Hand 
Surg Am. 2018;43:1000–1009.e1. 
 16. Tsehaie J, Spekreijse KR, Wouters RM, et al.; Hand-Wrist 
Study Group. Predicting outcome after hand orthosis and 
hand therapy for thumb carpometacarpal osteoarthritis: A 
prospective study. Arch Phys Med Rehabil. 2019;100:844–850. 
 17. Jansen MC, Evers S, Slijper HP, et al. Predicting clinical out-
come after surgical treatment in patients with carpal tunnel 
syndrome. J Hand Surg Am. 2018;43:1098–1106.e1. 
 18. Evers S, Jansen MC, Slijper HP, et al. Hand surgeons per-
forming more open carpal tunnel releases do not show better 
patient outcomes. Plast Reconstr Surg. 2018;141:1439–1446. 
 19. Sun PO, Selles RW, Jansen MC, Slijper HP, Ulrich DJO, 
Walbeehm ET. Recurrent and persistent carpal tunnel syn-
drome: Predicting clinical outcome of revision surgery. J 
Neurosurg. 2019:1–9. Epublished ahead of print. 
 20. Zhou C, Ceyisakar IE, Hovius SER, et al. Surgeon volume and 
the outcomes of Dupuytren’s surgery: Results from a Dutch 
multicenter study. Plast Reconstr Surg. 2018;142:125–134. 
 21. Zhou C, Hovius SE, Slijper HP, et al. Predictors of patient satis-
faction with hand function after fasciectomy for Dupuytren’s 
contracture. Plast Reconstr Surg. 2016;138:649–655. 
 22. Tsehaie J, van der Oest MJW, Poelstra R, et al. 
Trapeziometacarpal osteoarthritis: Positive experience with 
treatment is associated with better surgical outcome. J Hand 
Surg Eur Vol. 2019;44:714–721. 
 23. Festen-Schrier VJMM, Poelstra R, Selles RW, et al. Better 
patient-reported experiences with health care are associated 
with improved clinical outcome after carpal tunnel release 
surgery. Plast Reconstr Surg. 2019;143:1677–1684.
 24. van Kooij Y, Poelstra R, Porsius JT, Slijper HP, Warwick 
D, Selles RW. The Patient Specific Functional Scale in 
Dupuytren’s disease; a more responsive outcome measure 
than standardized PROMS? Paper presented at: 14th IFSSH-
11th IFSHT; June 17–21, 2019; Berlin, Germany.
 25. van der Oest MJW, Porsius JT, MacDermid JC, Slijper HP, 
Selles RW. Item reduction of the patient-rated wrist evalua-
tion using decision tree modelling. Disabil Rehabil. 2019:1–8. 
Epublished ahead of print. 
 26. Jansen MC, van der Oest MJ, Slijper HP, Porsius JT, 
Selles RW. Item reduction of the Boston Carpal Tunnel 
Questionnaire using decision tree modeling. Arch Phys Med 
Rehabil. 2019;100:2308–2313. 
 27. Edwards PJ, Roberts I, Clarke MJ, et al. Methods to increase 
response to postal and electronic questionnaires. Cochrane 
Database Syst Rev. 2009;3:MR000008. 
 28. Arner M. Developing a national quality registry for hand 
surgery: Challenges and opportunities. EFORT Open Rev. 
2016;1:100–106. 
 29. de Putter CE, Selles RW, Polinder S, Panneman MJ, Hovius 
SE, van Beeck EF. Economic impact of hand and wrist inju-
ries: Health-care costs and productivity costs in a population-
based study. J Bone Joint Surg Am. 2012;94:e56. 
 30. Sears ED, Swiatek PR, Hou H, Chung KC. The influence of 
insurance type on management of carpal tunnel syndrome: 
An analysis of nationwide practice trends. Plast Reconstr Surg. 
2016;138:1041–1049. 
 31. Manley OWG, Wormald JCR, Furniss D. The changing shape 
of hand trauma: An analysis of hospital episode statistics in 
England. J Hand Surg Eur Vol. 2019;44:532–536. 
 32. Craig RS, Lane JCE, Carr AJ, Furniss D, Collins GS, Rees JL. 
Serious adverse events and lifetime risk of reoperation after 
elective shoulder replacement: Population based cohort study 
using hospital episode statistics for England. BMJ 2019;364:l298. 
Copyright ©  American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited. 
354
Plastic and Reconstructive Surgery • August 2020
 33. de Groot JA, Janssen KJ, Zwinderman AH, Bossuyt PM, 
Reitsma JB, Moons KG. Correcting for partial verification bias: 
A comparison of methods. Ann Epidemiol. 2011;21:139–148. 
 34. Little RJA. A test of missing completely at random for multivari-
ate data with missing values. J Am Stat Assoc. 1988;83:1198–1202.
 35. Little RJ, D’Agostino R, Cohen ML, et al. The prevention 
and treatment of missing data in clinical trials. N Engl J Med. 
2012;367:1355–1360. 
 36. Zeger SL, Liang KY. Longitudinal data analysis for discrete 
and continuous outcomes. Biometrics 1986;42:121–130.
 37. Martín-Merino E, Calderón-Larrañaga A, Hawley S, et al. 
The impact of different strategies to handle missing data 
on both precision and bias in a drug safety study: A multi-
database multinational population-based cohort study. Clin 
Epidemiol. 2018;10:643–654. 
 38. van de Ven-Stevens LA, Graff MJ, Selles RW, et al. Instruments 
for assessment of impairments and activity limitations in 
patients with hand conditions: A European Delphi study. J 
Rehabil Med. 2015;47:948–956. 
 39. Goldhahn J, Beaton D, Ladd A, Macdermid J, Hoang-Kim 
A; Distal Radius Working Group of the International Society 
for Fracture Repair (ISFR); International Osteoporosis 
Foundation (IOF). Recommendation for measuring clinical 
outcome in distal radius fractures: A core set of domains for 
standardized reporting in clinical practice and research. Arch 
Orthop Trauma Surg. 2014;134:197–205. 
 40. Waljee JF, Ladd A, MacDermid JC, Rozental TD, Wolfe SW; 
Distal Radius Outcomes Consortium. A unified approach to 
outcomes assessment for distal radius fractures. J Hand Surg 
Am. 2016;41:565–573. 
 41. Wittoek R, Kroon FPB, Kundakci B, et al. Report from the 
Hand Osteoarthritis Working Group at OMERACT 2018: 
Update on core instrument set development. J Rheumatol. 
2019;46:1183–1187. 
 42. International Consortium for Health Outcome Measurement 
(website). Available at: https://www.ichom.org/. Accessed 
June 8, 2020.
